Statera Biopharma Alpha and Beta Analysis
| STABDelisted Stock | USD 0.04 0.0003 0.82% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Statera Biopharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Statera Biopharma over a specified time horizon. Remember, high Statera Biopharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Statera Biopharma's market risk premium analysis include:
Beta (0.50) | Alpha (1.60) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Statera |
Statera Biopharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Statera Biopharma market risk premium is the additional return an investor will receive from holding Statera Biopharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Statera Biopharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Statera Biopharma's performance over market.| α | -1.6 | β | -0.5 |
Statera Biopharma Fundamentals Vs Peers
Comparing Statera Biopharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Statera Biopharma's direct or indirect competition across all of the common fundamentals between Statera Biopharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Statera Biopharma or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Statera Biopharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Statera Biopharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Statera Biopharma to competition |
| Fundamentals | Statera Biopharma | Peer Average |
| Return On Equity | -2.87 | -0.31 |
| Return On Asset | -0.24 | -0.14 |
| Operating Margin | (5.73) % | (5.51) % |
| Current Valuation | 12.92 M | 16.62 B |
| Shares Outstanding | 54.66 M | 571.82 M |
| Shares Owned By Insiders | 15.93 % | 10.09 % |
| Shares Owned By Institutions | 5.41 % | 39.21 % |
Statera Biopharma Opportunities
Statera Biopharma Return and Market Media
The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
About Statera Biopharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Statera or other pink sheets. Alpha measures the amount that position in Statera Biopharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Statera Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Statera Biopharma's short interest history, or implied volatility extrapolated from Statera Biopharma options trading.
Build Portfolio with Statera Biopharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Statera Pink Sheet
If you are still planning to invest in Statera Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Statera Biopharma's history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |